...
首页> 外文期刊>Medicinal chemistry >3D-QSAR and docking studies on a series of benzothiadiazine derivatives as genotype 1 HCV polymerase inhibitors
【24h】

3D-QSAR and docking studies on a series of benzothiadiazine derivatives as genotype 1 HCV polymerase inhibitors

机译:3D-QSAR和一系列作为基因型1 HCV聚合酶抑制剂的苯并噻二嗪衍生物的对接研究

获取原文
获取原文并翻译 | 示例

摘要

The Benzothiadiazine derivatives have been regarded as a novel class of HCV genotype 1 polymerase inhibitors. To explore the relationship between the structures of substituted Benzothiadiazine derivatives and their inhibitory activities against HCV, 3D-QSAR and molecular docking studies were performed on a dataset of ninty-eight compounds. The 3D-QSAR models resulted from seventy-eight molecules in the training set gave q 2 value of 0.81 and a test set of twenty compounds, gave predictive r 2 value of 0.94. 3D-QSAR model generated from kNN-MFA along with the docking binding structures provided enough information about the structural requirements for better activity. The results can serve as a useful guideline to design novel HCV genotype 1 inhibitors with better potencies.
机译:苯并噻二嗪衍生物被认为是一类新的HCV基因型1聚合酶抑制剂。为了探索取代的苯并噻二嗪衍生物的结构与其对HCV的抑制活性之间的关系,对98个化合物的数据集进行了3D-QSAR和分子对接研究。由训练集中的78个分子产生的3D-QSAR模型给出的q 2值为0.81,测试集包含20种化合物,给出的预测r 2值为0.94。从kNN-MFA生成的3D-QSAR模型以及对接绑定结构提供了有关结构要求的更多信息,以实现更好的活动。该结果可作为设计具有更高效力的新型HCV基因型1抑制剂的有用指导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号